We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Webinar Recordings » Combination Products: Managing Design Controls - Webinar CD/Transcript

Other Options

Audio CD/Transcript - Aug. 15, 2017

$287.00

Audio CD/Transcript - Aug. 15, 2017

$258.00

Audio CD/Transcript - Aug. 15, 2017

$244.00

Audio CD/Transcript - Aug. 15, 2017

$230.00

Audio CD/Transcript - Aug. 15, 2017

$215.00

Combination Products: Managing Design Controls - Webinar CD/Transcript

$287.00
Webinar Recordings

Product Details

Combination Products: Managing Design Controls

Planning to submit a new combination product for FDA approval? Then consider this:

The final guidance regarding Current Good Manufacturing Practice Requirements for Combination Products — the document that may hold the key to success or failure — is a lot more nuanced than many realize.

The Guidance addresses an often overlooked aspect of product regulation — the design control of the device component. Insufficient compliance can lead a Complete Response Letter that denies your application for failure to consider and/or address design control elements.

FDAnews has stepped into this knowledge gap with an all-new Webinar featuring Ricki Chase, former Director of the FDA Investigations Branch and now a management consultant. Ms. Chase analyzes this all-important final guidance ... for you. Prepare to learn:

  • How design controls apply to combination products, including biologic/device and drug/device combinations ...
  • How already available information can help speed new products to market ...
  • Why a device isn’t a combination product: Designing for the differences ...
  • Using human factor studies to support combination-product submissions ...
  • And much more!

A Complete Response Letter can spell defeat for years of planning and design, not to mention hundreds of thousands of wasted dollars. Don’t take that risk.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing